|
Larodan
larodan fine chemicals Larodan Fine Chemicals, supplied by Larodan, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/larodan fine chemicals/product/Larodan Average 93 stars, based on 1 article reviews
larodan fine chemicals - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Larodan
lpc Lpc, supplied by Larodan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lpc/product/Larodan Average 90 stars, based on 1 article reviews
lpc - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Proteintech
monoclonal antibody against lpcat1 ![]() Monoclonal Antibody Against Lpcat1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/monoclonal antibody against lpcat1/product/Proteintech Average 93 stars, based on 1 article reviews
monoclonal antibody against lpcat1 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pcr amplified rest ![]() Pcr Amplified Rest, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pcr amplified rest/product/Addgene inc Average 93 stars, based on 1 article reviews
pcr amplified rest - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Proteintech
antilpcat2 ![]() Antilpcat2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/antilpcat2/product/Proteintech Average 94 stars, based on 1 article reviews
antilpcat2 - by Bioz Stars,
2026-04
94/100 stars
|
Buy from Supplier |
|
Croda International Plc
c16 plasm lpc avanti ![]() C16 Plasm Lpc Avanti, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/c16 plasm lpc avanti/product/Croda International Plc Average 91 stars, based on 1 article reviews
c16 plasm lpc avanti - by Bioz Stars,
2026-04
91/100 stars
|
Buy from Supplier |
|
Croda International Plc
standards ![]() Standards, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/standards/product/Croda International Plc Average 95 stars, based on 1 article reviews
standards - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
Proteintech
mouse monoclonal anti lpcat1 ![]() Mouse Monoclonal Anti Lpcat1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse monoclonal anti lpcat1/product/Proteintech Average 93 stars, based on 1 article reviews
mouse monoclonal anti lpcat1 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Larodan
16 0 2h3 larodan ab ![]() 16 0 2h3 Larodan Ab, supplied by Larodan, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/16 0 2h3 larodan ab/product/Larodan Average 92 stars, based on 1 article reviews
16 0 2h3 larodan ab - by Bioz Stars,
2026-04
92/100 stars
|
Buy from Supplier |
|
Proteintech
pcsk7 rabbit monoclonal antibody proteintech ![]() Pcsk7 Rabbit Monoclonal Antibody Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pcsk7 rabbit monoclonal antibody proteintech/product/Proteintech Average 93 stars, based on 1 article reviews
pcsk7 rabbit monoclonal antibody proteintech - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
anxa1 ![]() Anxa1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anxa1/product/MedChemExpress Average 93 stars, based on 1 article reviews
anxa1 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Larodan
sn-1-18 ![]() Sn 1 18, supplied by Larodan, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sn-1-18/product/Larodan Average 93 stars, based on 1 article reviews
sn-1-18 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Oncology
Article Title: LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism
doi: 10.3389/fonc.2026.1707270
Figure Lengend Snippet: LPCAT1 is upregulated in HCC and shows coordinated associations with ICB activity and immune-stromal infiltration. (A–C) Association of LPCAT1 mRNAexpression levels with advanced T stage (A) , TNM stage (B) , and histologic grade (C) in the TCGA-LIHC cohort. (D, E) GSEA for samples with highLPCAT1 expression (D) and low expression (E) . (F) IHC shows stronger LPCAT1 protein in tumor tissue than in adjacent non-tumor tissue. Scalebar:100mm. (G) LPCAT1 IHC staining was stronger in TNM stage III than in stage I tumors. Scale bar:100mm. (H) Box plot showed the ratio differentiation of 21 kinds of immune cells between LIHC tumor samples with low or high LPCAT1 expression relative to the median of LPCAT1 expression level. P values were adjusted for multiple comparisons using the Benjamini-Hochberg method. **Adjusted p < 0.01, ***adjusted p < 0.001. (I) Immune checkpoint genes expression levels in the high and low LPCAT1 expression in TCGA. **p < 0.01; ***p < 0.001.
Article Snippet: Tissue sections (4 μm thick) were stained using a
Techniques: Activity Assay, Expressing, Immunohistochemistry
Journal: Frontiers in Oncology
Article Title: LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism
doi: 10.3389/fonc.2026.1707270
Figure Lengend Snippet: LPCAT1 drives HCC progression and confers therapeutic vulnerability via high-affinity interactions. (A) Western blot validation of LPCAT1 over-expression. (B) EdU proliferation assay showing increased DNA replication in LPCAT1-overexpressing cells. Scale bar:200μm (C) Colony formation assay demonstrating enhanced clonogenic capacity post-LPCAT1 over-expression. Scale bar: 200μm. (D) Wound healing assay was performed to evaluate the cell migration of LPCAT1-overexpressed Hepa1–6 cells. Scale bar: 100μm. (E, F) Transwell assays with/without matrigel coating for migration (E) and invasion (F) quantification. Scale bar:100μm. (G) The docking conformation and interaction force analysis of LPCAT1. *p < 0.05; **p < 0.01; ***p < 0.001.
Article Snippet: Tissue sections (4 μm thick) were stained using a
Techniques: Western Blot, Biomarker Discovery, Over Expression, Proliferation Assay, Colony Assay, Wound Healing Assay, Migration
Journal: Frontiers in Oncology
Article Title: LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism
doi: 10.3389/fonc.2026.1707270
Figure Lengend Snippet: Structural dynamics of LPCAT1-kinase inhibitor complexes. (A-C) RMSD plots for (A) sorafenib, (B) lenvatinib, and (C) regorafenib complexes. (D-F) RMSF of LPCAT1 in complex with (D) sorafenib, (E) lenvatinib, and (F) regorafenib. (G-I) Ligand RMSF for (G) sorafenib, (H) lenvatinib, and (I) regorafenib. (J-L) Secondary structure evolution of LPCAT1 bound to (J) sorafenib, (K) lenvatinib, and (L) regorafenib.
Article Snippet: Tissue sections (4 μm thick) were stained using a
Techniques:
Journal: Frontiers in Oncology
Article Title: LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism
doi: 10.3389/fonc.2026.1707270
Figure Lengend Snippet: Interaction landscapes and binding metrics. (A–C) Sorafenib binding mode: (A) Interaction types between sorafenib and LPCAT1. (B) TRP163 distance. (C) PHE513 distance. (D–F) Lenvatinib interaction dynamics: (D) Interaction types between lenvatinib and LPCAT1. (E) CYS514 distance. (F) TRP247 distance. (G–I) regorafenib interaction dynamics: (G) Interaction types between regorafenib and LPCAT1. (H) PHE206 distance. (I) ARG183 distance.
Article Snippet: Tissue sections (4 μm thick) were stained using a
Techniques: Binding Assay
Journal: Frontiers in Oncology
Article Title: LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism
doi: 10.3389/fonc.2026.1707270
Figure Lengend Snippet: Interaction landscapes and binding metrics. (A–C) RMSD plots for (A) PD1-LPCAT1, (B) PDL1-LPCAT1, and (C) CTLA4-LPCAT1. (D–F) Interface residue RMSF for (D) PD1-LPCAT1, (E) PDL1-LPCAT1, and (F) CTLA4-LPCAT1. (G–I) Secondary structure conservation in (G) PD1, (H) PDL1, and (I) CTLA4 complexes.
Article Snippet: Tissue sections (4 μm thick) were stained using a
Techniques: Binding Assay, Residue
Journal: Cell metabolism
Article Title: Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling
doi: 10.1016/j.cmet.2019.06.014
Figure Lengend Snippet: KEY RESOURCES TABLE
Article Snippet:
Techniques: Recombinant, Membrane, Transfection, SYBR Green Assay, Bicinchoninic Acid Protein Assay, Negative Control, Empire Assay, Plasmid Preparation, shRNA, Control, Sequencing, Software
Journal: Nature Communications
Article Title: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils
doi: 10.1038/s41467-025-59050-4
Figure Lengend Snippet: A The UMAP plot shows five epithelial subtypes in distinct colors, with bar graphs indicating their quantities. B The UMAP plot (left) shows the distributions of control, resistant, and sensitive groups, with cell proportions (center) and subtype compositions (right). C Heatmap of top 10 signature genes for three groups. D CellChat circle plot shows differences in intercellular communication number and strength between two groups. E The UMAP plot shows 11 immune cell subtypes, with bar graphs indicating their numbers. F The UMAP plot shows 11 immune subtypes across two groups. G CellChat analysis compares epithelial-immune information flow in Resi and Sens groups, with relative (left) and absolute (right) flow shown. H Scatter plot of ANNEXIN pathway signaling in cell clusters from CellChat analysis. Bubble plots from CellChat ( I ) and CellPhoneDB (J) show epithelial subtype communication with Neu1 receptors and ligands. P values were calculated using a permutation test, assessing the significance of cell-cell communication by comparing observed mean expression with a null distribution generated by random permutations ( I ). P values were calculated using a permutation test, which generates a null distribution by randomly shuffling cell labels to determine the specificity of interactions ( J ). P values are one-sided and exact. K Violin plot (left) and FeaturePlot (right) show Anxa1 expression in epithelial cells across groups. The box plot elements are defined as described in the Statistics and Reproducibility section. Each group includes cells from 3 mice. P values were calculated one-way ANOVA. L Violin plot showing Anxa1 expression across epithelial cell subtypes. The box plot elements are defined as described in the Statistics and Reproducibility section. Each group includes cells from 9 mice. P values were calculated one-way ANOVA. M Representative IHC staining and score of Anxa1 in HNSCC. n = 6 control, n = 6 resistant, n = 8 sensitive mice. Scale bar = 65 μm. Data shown as as mean ± SD. P values were calculated one-way ANOVA with Tukey’s multiple comparisons test. Source data and exact p values are provided as a file.
Article Snippet: Following a previously published method, HL60 cells were incubated with 500 nM
Techniques: Control, Expressing, Generated, Immunohistochemistry
Journal: Nature Communications
Article Title: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils
doi: 10.1038/s41467-025-59050-4
Figure Lengend Snippet: A The experimental design of the HNSCC tumorigenesis model and treatment strategy in the Resi; Anxa1 cKO-Con and Resi; Anxa1 cKO groups. B Representative image of tongue visible lesions in Resi; Anxa1 cKO-Con and Resi; Anxa1 cKO groups. n = 6 mice in each group. Scale bar, 2 mm. C Quantification of HNSCC lesion number and lesion area (mm 3 ) in Resi; Anxa1 cKO-Con and Resi; Anxa1 cKO groups. n = 6 mice in each group. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. D Representative H&E staining of HNSCC and Quantification of HNSCC invasion grades in Resi; Anxa1 cKO-Con and Resi; Anxa1 cKO groups. Scale bar, 65 μm. n = 6 mice in each group. Statistical significance was assessed using the Pearson chi-square test. P value is exact and two-sided. Representative IHC staining and IHC Score of Ki67 ( E ), Anxa1 ( F ), and Fpr1 ( G ) in HNSCC of Resi; Anxa1 cKO-Con and Resi; Anxa1 cKO groups. The scale bar is 65 μm. n = 6 mice in each group. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. Representative immunofluorescence staining of Gzma+γδT ( H ) or Gzma+Cd8 T ( I ) cells in mouse HNSCC tissues from Resi; Anxa1 cKO-Con and Resi; Anxa1 cKO groups. Epithelial tissues were stained with anti-Gzma antibody (green) and anti-Tcr g/d ( H ) or anti-Cd8a ( I ) antibody (red). Cell nuclei were stained with DAPI (blue). Scale bar, 30 μm. On the right, the corresponding percentages of Gzma+γδT ( H ) or Gzma+Cd8 T ( I ) cells in terms of area and number are provided. n = 6 mice in each group. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. Source data and exact p values are provided as a file.
Article Snippet: Following a previously published method, HL60 cells were incubated with 500 nM
Techniques: Two Tailed Test, Staining, Immunohistochemistry, Immunofluorescence
Journal: Nature Communications
Article Title: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils
doi: 10.1038/s41467-025-59050-4
Figure Lengend Snippet: A Venn diagram of genes identified by FindMarkers and SCENIC analyses. B Violin plot (left) shows Sox9 expression across groups, and FeaturePlot (right) depicts Sox9 expression in epithelial cells. The box plot elements are defined as described in the Statistics and Reproducibility section. Each group includes cells from 3 mice. P values were calculated one-way ANOVA. C Violin plot showing Sox9 expression across epithelial cell subtypes. The box plot elements are defined as described in the Statistics and Reproducibility section. Each group includes cells from 9 mice. P values were calculated one-way ANOVA. D Representative IHC staining and score of Sox9 in HNSCC. n = 6 control, n = 6 resistant, n = 8 sensitive mice. Scale bar = 65 μm. Data shown as mean ± SD. P values were calculated one-way ANOVA with Tukey’s multiple comparisons test. E ChIP of genomic DNA from resistant mouse HNSCC tissues was performed with a Sox9-specific antibody. Left: gel image, right: qPCR analysis of Anxa1 promoter ChIP signal relative to IgG group. Two primer pairs were used. The experiment was independently repeated three times. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. F Luciferase reporter assay assessed Anxa1 promoter activity in Moc1 cells. A schematic diagram shows cloning the Anxa1 promoter into the pZX001 vector to generate pGL3 luciferase plasmid. Binding motif information was retrieved from footprintDB database. G The relative activity of the Anxa1 promoter was detected by luciferase assay across the three groups. The experiment was independently repeated three times. Data shown as mean ± SD. P values were calculated one-way ANOVA with Tukey’s multiple comparisons test. H Representative immunofluorescence colocalization of Anxa1 (red) and Sox9 (green) in Resi mouse HNSCC tissues. Nuclei counterstained with DAPI (blue). Scale bar = 20 μm. Source data and exact p values are provided as a file.
Article Snippet: Following a previously published method, HL60 cells were incubated with 500 nM
Techniques: Expressing, Immunohistochemistry, Control, Two Tailed Test, Luciferase, Reporter Assay, Activity Assay, Cloning, Plasmid Preparation, Binding Assay, Immunofluorescence
Journal: Nature Communications
Article Title: Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils
doi: 10.1038/s41467-025-59050-4
Figure Lengend Snippet: A The experimental design of the HNSCC tumorigenesis model and treatment strategy in the Resi; DTR+ and Resi; DTR− groups. B Representative image of tongue visible lesions in Resi; DTR+ and Resi; DTR− groups. n = 6 mice in each group. Scale bar, 2 mm. C Quantification of HNSCC lesion number and lesion area (mm 3 ) in Resi; DTR+ and Resi; DTR− groups. n = 6 mice in each group. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. D Representative H&E staining of HNSCC and Quantification of HNSCC invasion grades in Resi; DTR+ and Resi; DTR− groups. Scale bar, 65 μm. n = 6 mice in each group. Statistical significance was assessed using the Pearson chi-square test. P value is exact and two-sided. Representative IHC staining and IHC Score of Ki67 ( E ), Sox9 ( F ), Anxa1 ( G ), and Fpr1 ( H ) in HNSCC of Resi; DTR+ and Resi; DTR− groups. The scale bar is 65 μm. n = 6 mice in each group. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. Representative immunofluorescence staining of Gzma+γδT ( I ) or Gzma+Cd8 T ( J ) cells in mouse HNSCC tissues from Resi; DTR+ and Resi; DTR− groups. Epithelial tissues were stained with anti-Gzma antibody (green) and anti-Tcr g/d ( I ) or anti-Cd8a ( J ) antibody (red). Cell nuclei were stained with DAPI (blue). Scale bar, 30 μm. On the right, the corresponding percentages of Gzma+γδT ( I ) or Gzma+Cd8 T ( J ) cells in terms of area and number are provided. n = 6 mice in each group. Data shown as mean ± SD. P values are presented by two-tailed unpaired Student’s t test. Source data and exact p values are provided as a file.
Article Snippet: Following a previously published method, HL60 cells were incubated with 500 nM
Techniques: Two Tailed Test, Staining, Immunohistochemistry, Immunofluorescence